DA
JNJ icon

Detalus Advisors’s Johnson & Johnson JNJ Stock Holding History

Detalus Advisors’s Portfolio JNJ Stock Details JNJ Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.23M Sell
4,831
-17
-0.4% -$3.96K 0.24% 54
2026
Q1 		$1.19M Sell
4,848
-100
-2% -$23.3K 0.27% 51
2025
Q4 		$1.02M Buy
4,948
+71
+1% +$14K 0.25% 54
2025
Q3 		$904K Sell
4,877
-89
-2% -$15.2K 0.23% 58
2025
Q2 		$758K Sell
4,966
-57
-1% -$8.76K 0.22% 61
2025
Q1 		$833K Buy
5,023
+91
+2% +$14.2K 0.26% 55
2024
Q4 		$713K Buy
4,932
+25
+0.5% +$3.87K 0.23% 56
2024
Q3 		$795K Buy
4,907
+277
+6% +$44.1K 0.26% 53
2024
Q2 		$677K Buy
4,630
+10
+0.2% +$1.49K 0.23% 60
2024
Q1 		$731K Sell
4,620
-53
-1% -$8.44K 0.26% 55
2023
Q4 		$732K Sell
4,673
-202
-4% -$31K 0.29% 52
2023
Q3 		$759K Sell
4,875
-672
-12% -$111K 0.36% 51
2023
Q2 		$918K Buy
5,547
+501
+10% +$80.9K 0.41% 44
2023
Q1 		$782K Sell
5,046
-79
-2% -$12.8K 0.37% 50
2022
Q4 		$905K Buy
5,125
+445
+10% +$76.8K 0.44% 45
2022
Q3 		$765K Sell
4,680
-115
-2% -$19.5K 0.46% 45
2022
Q2 		$851K Sell
4,795
-343
-7% -$61.1K 0.5% 36
2022
Q1 		$911K Sell
5,138
-369
-7% -$62.8K 0.48% 37
2021
Q4 		$942K Sell
5,507
-271
-5% -$44.4K 0.45% 37
2021
Q3 		$933K Sell
5,778
-329
-5% -$56.1K 0.47% 35
2021
Q2 		$1.01M Buy
6,107
+400
+7% +$66.2K 0.54% 33
2021
Q1 		$938K Buy
5,707
+155
+3% +$25.1K 0.55% 31
2020
Q4 		$874K Buy
5,552
+226
+4% +$33.4K 0.55% 29
2020
Q3 		$793K Sell
5,326
-20
-0.4% -$2.96K 0.58% 26
2020
Q2 		$752K Sell
5,346
-317
-6% -$46.2K 0.58% 23
2020
Q1 		$743K Buy
5,663
+64
+1% +$9.08K 0.68% 23
2019
Q4 		$817K Buy
+5,599
New +$759K 0.6% 27

Other funds holding JNJ

Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
AACR
ACR Alpine Capital Research St. Louis, Missouri $7.04B AUM 28% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $54.2B AUM 43.77% 1-Year Est. Return

Detalus Advisors's JNJ Position: Q2 2026 in Review

Detalus Advisors reduced its Johnson & Johnson (JNJ) stake by 0.35% in Q2 2026, selling an estimated $3.96K and leaving 4,831 shares worth $1.23M. The position accounts for 0.24% of the portfolio, ranked #54.

Detalus Advisors first reported a position in JNJ in Q4 2019 and has held it in 27 quarters since. 2,253 funds tracked by Wall St. Rank hold JNJ as of Q2 2026.

  • Detalus Advisors held 4,831 shares of Johnson & Johnson worth $1.23M as of Q2 2026.
  • Detalus Advisors sold 17 Johnson & Johnson shares in Q2 2026, an estimated $3.96K.
  • Johnson & Johnson made up 0.24% of Detalus Advisors's portfolio in Q2 2026, its #54 holding.
  • Detalus Advisors first reported a position in Johnson & Johnson in Q4 2019 and has held it in 27 quarters since.
  • 2,253 funds tracked by Wall St. Rank held Johnson & Johnson as of Q2 2026.

Based on Detalus Advisors's 13F filing for Q2 2026, filed 27 Jul 2026.